Long-Term Guselkumab Effective in Dactylitis and Enthesitis Resolution in Patients With Psoriatic Arthritis
Researchers evaluated the long-term effect of guselkumab on resolution of dactylitis and enthesitis in patients with psoriatic arthritis.
Researchers evaluated the long-term effect of guselkumab on resolution of dactylitis and enthesitis in patients with psoriatic arthritis.
Methotrexate with targeted escalation resulted in significant improvement in the skin, joint, dactylitis, enthesitis, and functional domains of PsA.
The Psoriatic Arthritis Impact of Disease questionnaire was endorsed as a core outcome measure for psoriatic arthritis-specific health-related quality of life.
Recent research points to an association between the gut microbiome composition and various types of immune-mediated inflammatory arthritides.
Patients with axial spondyloarthritis who have inflammatory back pain or neuropathic pain may have higher pain intensity, pain interference, disease activity, and greater functional limitation compared with individuals with axial spondyloarthritis but without either comorbidity.